European Medicines Evaluation Agency
7 Westferry Circus
Canary Wharf
London
E14 4HB
United Kingdom
Tel: 44-2074188400
Fax: 44-2074188416
Website: http://www.emea.europa.eu/
174 articles about European Medicines Evaluation Agency
-
Immune Response BioPharma to Seek BLA Approval of REMUNE With European Medicines Agency & Enter the Eurozone
7/12/2013
-
EpiCept Corporation Receives Scientific Advice from European Medicines Evaluation Agency for AmiKet™ CIPN Program
6/4/2012
-
European Medicines Evaluation Agency Clears Roche Cancer Drug MabThera
5/29/2012
-
European Medicines Evaluation Agency Confirms Boehringer Ingelheim Corporation's Pradaxa Benefits, But Wants Clearer Guidance
5/25/2012
-
European Medicines Evaluation Agency Supports Novartis AG' Gilenya With Stronger Warning
4/20/2012
-
Chairman of European Medicines Evaluation Agency Quits Suddenly
4/5/2012
-
European Medicines Evaluation Agency Wants Two More Drugs Moved From Ben Venue Laboratories Due to Ongoing Manufacturing Practice Concerns
3/20/2012
-
EXTEDO and Asphalion Will be Advising Life Sciences Firms on How to Comply With New European Medicines Evaluation Agency Regulations at Drug Information Association EuroMeeting
3/19/2012
-
Cytokinetics, Inc. Announces That the European Medicines Evaluation Agency Has Granted CK-2017357 Orphan Medicinal Product Designation for the Treatment of Amyotrophic Lateral Sclerosis
3/6/2012
-
Genzyme Corporation Announces European Medicines Evaluation Agency Accepts Oral Teriflunomide Marketing Application for Treatment of Multiple Sclerosis
2/23/2012
-
European Medicines Evaluation Agency Recommends Lifting Suspension of Bayer HealthCare's Trasylol
2/21/2012
-
European Medicines Evaluation Agency Decides Risk of Roche's Xenical and GlaxoSmithKline's Alli Diet Drug are OK
2/20/2012
-
Cell Therapeutics, Inc. Release: European Medicines Evaluation Agency Committee for Medicinal Products for Human Use Issues Positive Opinion for Conditional Approval on Marketing Authorization Application for Pixuvri™
2/17/2012
-
Navidea Biopharmaceuticals Obtains Positive European Medicines Evaluation Agency Guidance for Lymphoseek® (Tilmanocept); Company to Submit Marketing Authorization Application in Europe
2/2/2012
-
European Medicines Evaluation Agency Approves Orphan Medicinal Product Application of Dcprime's Acute Myeloid Leukemia Vaccine
2/1/2012
-
Allos Therapeutics, Inc. Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at theEuropean Medicines Evaluation Agency
1/30/2012
-
EXTEDO Extends Product Family to Help Life Sciences Firms Comply With New European Drug Safety Regulations
1/24/2012
-
Cell Therapeutics, Inc. Expects That the European Medicines Evaluation Agency Committee for Medicinal Products for Human Use (CHMP) May Issue an Opinion on the Marketing Authorization Application ("MAA") on Pixuvri(TM) in Mid-February
1/20/2012
-
Cell Therapeutics, Inc. European Medicines Evaluation Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012
12/5/2011
-
Starpharma Holdings Ltd Secures European Medicines Evaluation Agency Agreement on BV Treatment Phase 3
11/21/2011